Castaway lizards offer new look at evolutionary processes

Differences caused by 'founder effect' persist when populations adapt to new environments

2012-02-06

(Press-News.org) Biologists who released lizards on tiny uninhabited islands in the Bahamas have uncovered a seldom-observed interaction between evolutionary processes.

Jason Kolbe, a biologist at the University of Rhode Island (URI)--along with colleagues at Duke University, Harvard University and the University of California, Davis--found that the lizards' genetic and morphological (form and structural) traits were determined by both natural selection and a phenomenon called the founder effect.

Their research results are published online today in the journal Science.

The founder effect is the loss of genetic variation that occurs when a new population is established by a very small number of individuals from a larger population. It often results in the new population becoming genetically or morphologically different from the original population.

"We rarely observe the founder effect as it happens in nature, but we know that it occurs because islands are colonized by new species over time," said Kolbe.

"What we didn't know was how these evolutionary mechanisms [natural selection and the founder effect] interact with each other."

The scientists learned that differences caused by the founder effect persist even as populations adapt to new environments.

"Evolutionary biologists have been debating the importance of founder effects for more than 70 years," said Sam Scheiner, program director in the National Science Foundation (NSF)'s Division of Environmental Biology, which funded the research. "This study is the first to definitively demonstrate those effects for ecologically important traits."

Kolbe and colleagues randomly collected brown anole lizards from a large island near Great Abaco in the Bahamas, and released one pair on each of seven nearby islands whose lizard populations had been cleared by a recent hurricane.

The source island is forested, while the other islands have short, scrubby vegetation.

Previous research had found that anole lizards living in forests had longer hind limbs than those found in scrub habitat.

Lizards with longer limbs can run faster on the broad perches available in forests, while short-limbed lizards are more adept at moving on the narrower perches found in lower vegetation.

The scientists revisited each of the islands over the next four years to measure the lizards' limb length and collect tissue samples for genetic analysis.

All the new populations survived and increased an average of 13-fold in the first two years, before leveling off.

"We noticed a founder effect one year after starting the experiment, which resulted in differences among the lizards on the seven islands," Kolbe said.

"Some of the islands had lizards with longer limbs and some had lizards with shorter limbs, but that was random with respect to the vegetation on the new islands."

Because the structure of the vegetation on the islands differed from that of the source island, the scientists predicted that natural selection would lead the lizards to develop shorter limbs.

"Over the next four years, the lizards on all the islands experienced a decrease in leg length that is attributable to natural selection," Kolbe explained. "But those that started out with the longest hind limbs still had the longest hind limbs."

The fact that the populations maintained their order from longest to shortest limbs throughout the experiment means that both the founder effect and natural selection contributed to their current differences.

According to Kolbe, the founder effect is rarely observed in nature, with most previous research conducted in the laboratory.

"Ours is the first to study this process experimentally in a natural setting, and we were able to account for multiple evolutionary mechanisms through time," he said. "We manipulated the founding of these islands, but everything else about it was natural."

The next step in the research will be to determine how long the founder effect persists before other factors erase its signature.

INFORMATION:

Co-authors of the paper are Kolbe; Manuel Leal of Duke University; Thomas Schoener and David Spiller of the University of California, Davis; and Jonathan Losos of Harvard.

The study was also funded by the National Geographic Society.

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

New device performs better than old for removing blood clots

2012-02-06

An experimental blood clot-removing device outperformed the FDA-approved MERCI; retriever device, according to late-breaking science presented at the American Stroke Association's 2012 International Stroke Conference. The SOLITAIRE; Flow Restoration Device is a self-expanding stent-based design that mechanically removes blood clots from blocked vessels after a stroke. After insertion into the clot using a thin tube, or catheter, the device traps the clot then both device and clot are removed, restoring blood flow. The MERCI retriever uses a tiny corkscrew, guided by a ...

Clopidogrel with aspirin doesn't prevent more small strokes, may increase risk of bleeding, death

2012-02-06

The anti-blood clot regimen that adds the drug clopidogrel (Plavix) to aspirin treatment is unlikely to prevent recurrent strokes and may increase the risk of bleeding and death in patients with subcortical stroke according to late-breaking research presented at the American Stroke Association's International Stroke Conference 2012. Because of these preliminary results, researchers ended the anti-clotting part of the Secondary Prevention of Small Subcortical Strokes Trial (SPS3) in August 2011. The part of the study that examines the effect of high blood pressure treatments ...

New drug doesn't improve disability among stroke patients

2012-02-06

A new drug that showed promise in animal studies and an early clinical trial didn't improve disability among stroke patients, according to late-breaking research presented at the American Stroke Association's International Stroke Conference 2012. After a stroke and other types of brain damage, the brain naturally produces more granulocyte colony stimulating factor (G-CSF). The protein can prevent further cell injury by protecting nerve cells and boosting blood vessel growth. The new drug, AX200, is a manufactured form of G-CSF. Ninety days after treatment, patients ...

Vitamin D deficiency in geriatric patients

2012-02-06

The great majority of geriatric patients in a German rehabilitation hospital were found to have vitamin D deficiency. Stefan Schilling presents his study results in this week's issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2012; 109[3]: 33-8). In order to establish the vitamin D status in geriatric patients in Germany, the researchers measured 25-OH vitamin D in 1578 patients in the geriatric rehabilitation hospital in Trier after they had been examined on admission. Insufficiently high concentrations were found in 89% of patients, and 67% had severe ...

Rare mutations may help explain aneurysm in high-risk families

2012-02-06

An innovative approach to genome screening has provided clues about rare mutations that may make people susceptible to brain aneurysms, predisposing them to brain bleeds, according to preliminary late-breaking research presented at the American Stroke Association's International Stroke Conference 2012. For the first time, scientists applied a process called whole exome sequencing to seek gene mutations in families in which multiple relatives have intracranial aneurysms, a condition in which weakened, ballooned-out areas in arteries of the brain can rupture and cause a ...

Warfarin and aspirin are similar in heart failure treatment

2012-02-06

In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients with normal heart rhythm, according to late-breaking research presented at the American Stroke Association's International Stroke Conference 2012. "Although there was a warfarin benefit for patients treated for four or more years, overall, warfarin and aspirin were similar," said Shunichi Homma, M.D., lead author of the study and the Margaret Milliken Hatch Professor of Medicine at Columbia University ...

Scientists chart high-precision map of Milky Way's magnetic fields

2012-02-06

Scientists at the Naval Research Laboratory (NRL) are part of an international team that has pooled their radio observations into a database, producing the highest precision map to date of the magnetic field within our own Milky Way galaxy. The team, led by the Max Planck Institute for Astrophysics (MPA), used the database they created and were able to apply information theory techniques to produce the map, explains NRL's Dr. Tracy Clarke, a member of the research team. "The key to applying these new techniques is that this project brings together over 30 researchers ...

A new study shows how to boost the power of pain relief, without drugs

2012-02-06

Placebos reduce pain by creating an expectation of relief. Distraction—say, doing a puzzle—relieves it by keeping the brain busy. But do they use the same brain processes? Neuromaging suggests they do. When applying a placebo, scientists see activity in the dorsolateral prefrontal cortex. That's the part of the brain that controls high-level cognitive functions like working memory and attention—which is what you use to do that distracting puzzle. Now a new study challenges the theory that the placebo effect is a high-level cognitive function. The authors—Jason T. Buhle, ...

Schooling protects fleeing children from disease

2012-02-06

Refugee children have scant access to medical care and are particularly vulnerable to disease. Fresh research results from the University of Copenhagen show that just a few hours of schooling a week may have a pronounced positive impact on their health not only in childhood but later in life when they achieve adulthood. "There is an unambiguous link between health and schooling among refugee groups as they flee," says external Associate Professor Tania Dræbel, PhD from the Department of Public Health, University of Copenhagen, where she works as an expert in health among ...

The complex relationship between memory and silence

2012-02-06

People who suffer a traumatic experience often don't talk about it, and many forget it over time. But not talking about something doesn't always mean you'll forget it; if you try to force yourself not to think about white bears, soon you'll be imagining polar bears doing the polka. A group of psychological scientists explore the relationship between silence and memories in a new paper published in Perspectives on Psychological Science, a journal of the Association for Psychological Science. "There's this idea, with silence, that if we don't talk about something, it starts ...

Castaway lizards offer new look at evolutionary processes

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: